Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Amine Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110776470B details an iridium-catalyzed asymmetric hydrogenation method for chiral 3,4-dihydroquinazolinones with up to 98% ee, offering a scalable route for API intermediates.
Patent CN1328230C details asymmetric transfer hydrogenation of imines using Rh/Ru/Ir catalysts for high-purity pharmaceutical intermediates.
Patent CN105112468A reveals multi-enzyme systems for chiral amine synthesis. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with scalable biocatalysis.